Results 131 to 140 of about 5,718,659 (207)

Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantation. [PDF]

Ann Hematol
Yoshinaga N, Iwasaki M, Kato K, Kimura F, Hirayama M, Kanaya M, Morishima S, Uchida N, Doki N, Fukuda T, Kanda Y, Nishida T, Hasegawa Y, Kako S, Tanaka M, Kurokawa M, Asada N, Kawakita T, Kataoka K, Kondo Y, Imada K, Ichinohe T, Onizuka M, Atsuta Y, Kanda J.   +24 more
europepmc   +1 more source

Relapse risk after FLAMSA RIC based allogeneic hematopoietic stem cell transplantation in heavily pretreated AML patients. [PDF]

Bone Marrow Transplant
Ussmann J, Jentzsch M, Schwind S, Herling M, Vučinić V, Merz M, Hilgendorf I, Hochhaus A, Platzbecker U, Metzeler KH, Franke GN.   +10 more
europepmc   +1 more source

Evaluation of Current and Novel Dosing Strategies for Anti-Thymocyte Globulin in Adult Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

CPT Pharmacometrics Syst Pharmacol
Biris E, Selby PR, Meola TR, Reuter SE.
europepmc   +1 more source

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents. [PDF]

Am J Hematol
Fathima S, Wong MM, Gonzalez-Lugo J, Geyer SM, Alsugair A, Sirenko M, Langer KJ, Lasho TL, Finke C, Choi J, Abdul-Hay M, Ho G, Litzow MR, Matin A, Durani U, Hefazi M, Hogan WJ, Shah MV, Al-Kali A, Begna KH, Gangat N, Saliba AN, Go RS, Kewan T, Bartoo G, Kutzke J, McCullough K, Warrington KJ, Sullivan M, Reichard KK, Olteanu H, Murthy H, Badar T, Kusne Y, Palmer J, Chhabra S, Punwani N, Riwes M, McGuirk JP, Krakow EF, Langston A, Kourelis T, Dingli D, Foran J, Koster MJ, Patnaik MM, Beck DB, Alkhateeb HB, Mangaonkar AA.   +48 more
europepmc   +1 more source

Correction: Effect of pretransplant spleen volume on the prognosis of acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. [PDF]

Front Immunol
Liu W, Liu B, Pang L, Zhou L, Wang F, Zhang X, Wang Y.   +6 more
europepmc   +1 more source

Assessing the significance of cytomegalovirus reactivation in recipients of allogeneic hematopoietic stem cell transplantation: a cohort study. [PDF]

Braz J Med Biol Res
Oliveira LP, Paton EJA, Giovanardi MF, Silva AFD, Tavares LG, Fernandes CG, Dias JO, Fabreti-Oliveira RA.   +7 more
europepmc   +1 more source

TA-TMA occurring after sequential CD7 CAR-T cell therapy and allogeneic hematopoietic stem cell transplantation: a case report. [PDF]

Front Immunol
Zhang J, Ma L, Liu X, An Y, Zhao M, Li M, Zhang X, Liu J, Zhang R, Zhao M.   +9 more
europepmc   +1 more source

Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation Following Recent Invasive Mold Disease in Pediatric Patients. [PDF]

J Fungi (Basel)
Martínez Pérez K, Torres-Hernández D, Sanclemente N, Ramirez O, Portilla A, Buitrago J, López-Medina E.   +6 more
europepmc   +1 more source

Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma. [PDF]

Hematol Oncol
Itonaga H, Fukushima T, Muranushi H, Nakano N, Inoue Y, Tokunaga M, Fukuda T, Eto T, Kawakita T, Kato T, Ishikawa J, Yoshimitsu M, Uchida N, Mori Y, Saburi M, Suehiro Y, Ogata M, Kanda Y, Ishitsuka K, Atsuta Y, Fuji S.   +20 more
europepmc   +1 more source

Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation: a single-center experience. [PDF]

Blood Res
Tsai PL, Lu MY, Chang HH, Yang YL, Du CJ, Wu CH, Jou ST, Chou SW.   +7 more
europepmc   +1 more source